PureTech Health plc (PTCHF)
USD 2.2
(0.0%)
USD 2.2
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -105.91 Million | -178.79 Million | -158.27 Million | -131.82 Million | -98.15 Million | -72.79 Million |
| Net Income | -65.69 Million | -37.06 Million | -62.7 Million | 4.56 Million | 366.06 Million | -70.65 Million |
| Depreciation & Amortization | 4.93 Million | 8.89 Million | 7.28 Million | 6.64 Million | 6.66 Million | 2.77 Million |
| Deferred income taxes | 32.81 Million | -70.12 Million | -112.61 Million | -151.34 Million | -546.61 Million | -19.41 Million |
| Stock-based compensation | 4.41 Million | 14.69 Million | 13.95 Million | 10.71 Million | 14.46 Million | 12.63 Million |
| Change in working capital | 17.51 Million | 15.91 Million | 861 Thousand | -8.52 Million | 15.02 Million | 9.96 Million |
| Other non-cash items | -99.21 Million | -111.11 Million | -5.05 Million | 6.11 Million | 46.22 Million | -8.09 Million |
| Investing Cash Flow | 68.99 Million | -107.22 Million | 197.37 Million | 364.47 Million | 63.65 Million | -39.64 Million |
| Investments in PPE | -245 Thousand | -2.17 Million | -5.66 Million | -5.42 Million | -12.53 Million | -4.49 Million |
| Acquisitions | -12.91 Million | -20.44 Million | 321 Thousand | -10 Million | -16.03 Million | -13.39 Million |
| Investment purchases | -195.71 Million | -268.73 Million | -500 Thousand | -1.15 Million | -91.24 Million | -169.95 Million |
| Sales/Maturities of investments | 277.86 Million | 183.71 Million | 218.12 Million | 380.7 Million | 183.28 Million | 148.06 Million |
| Other Investing Activities | 69.06 Million | 416 Thousand | -14.91 Million | 350 Thousand | 191 Thousand | 125 Thousand |
| Financing Cash Flow | 78.14 Million | -29.82 Million | 22.72 Million | 38.86 Million | 49.91 Million | 156.88 Million |
| Debt repayment | -100 Million | -393 Thousand | -2.21 Million | -39.72 Million | -178 Thousand | -185 Thousand |
| Dividends payments | - | - | - | - | -112 Thousand | -8000.00 |
| Common Stock Repurchased | -19.65 Million | -26.49 Million | -2.58 Million | - | 1.2 Million | -35 Thousand |
| Common Stock Issuance | 1.15 Million | 332 Thousand | -12.91 Million | -11.76 Million | 50.27 Million | 152.03 Million |
| Other Financing Activities | -24 Thousand | -2.88 Million | 40.8 Million | 90.34 Million | -1.28 Million | 6.14 Million |
| Accounts receivables | 9.75 Million | -7.73 Million | -617 Thousand | -529 Thousand | 747 Thousand | 467 Thousand |
| Accounts payables | 3.84 Million | 22.03 Million | 8.33 Million | 605 Thousand | 11.16 Million | 5.09 Million |
| Inventory | - | - | -102.99 Thousand | - | - | - |
| Other working capital | 2.55 Million | 1.62 Million | -6.75 Million | -8.6 Million | 3.11 Million | 4.4 Million |
| Cash at beginning of period | 151.99 Million | 465.7 Million | 403.88 Million | 132.36 Million | 117.05 Million | 72.64 Million |
| Cash at end of period | 192.7 Million | 149.86 Million | 465.7 Million | 403.88 Million | 132.36 Million | 117.05 Million |
| Capital Expenditure | -245 Thousand | -2.17 Million | -5.66 Million | -5.42 Million | -12.53 Million | -4.49 Million |
| Effect of forex changes on cash | - | - | -1000.00 | 1000.00 | -104 Thousand | -44 Thousand |
| Net cash flow / Change in cash | 40.71 Million | -315.84 Million | 61.82 Million | 271.52 Million | 15.3 Million | 44.4 Million |
| Free Cash Flow | -106.16 Million | -180.96 Million | -163.93 Million | -137.25 Million | -110.69 Million | -77.28 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -20.88 Million | -20.88 Million | -65.69 Million | -40.36 Million | -20.34 Million | -25 Million |
| Depreciation & Amortization | 907 Thousand | 907 Thousand | 4.93 Million | 1.85 Million | 936 Thousand | 3.06 Million |
| Deferred income taxes | - | - | 32.81 Million | 32.55 Million | - | -6.82 Million |
| Stock-based compensation | 2.32 Million | 2.32 Million | 4.41 Million | 1.57 Million | 1.57 Million | 628 Thousand |
| Change in working capital | -37 Thousand | -37 Thousand | 17.51 Million | 15.28 Million | 1.13 Million | 2.08 Million |
| Other non-cash items | -22.31 Million | -22.31 Million | -99.21 Million | -59.12 Million | -3.69 Million | -39.08 Million |
| Investing Cash Flow | 118.25 Million | 118.25 Million | 68.99 Million | -105.44 Million | -52.44 Million | 173.88 Million |
| Investments in PPE | - | - | -245 Thousand | -173.05 Thousand | - | -70 Thousand |
| Acquisitions | 188 Thousand | - | -12.91 Million | 377.66 Thousand | - | -13.19 Million |
| Investment purchases | -213.03 Million | - | -195.71 Million | -178.8 Million | - | -15.35 Million |
| Sales/Maturities of investments | 449.35 Million | - | 277.86 Million | 73.15 Million | - | 202.5 Million |
| Other Investing Activities | 118.25 Million | 118.25 Million | 69.06 Million | -52.44 Million | -52.44 Million | 86.97 Million |
| Financing Cash Flow | -19.55 Million | -19.55 Million | 78.14 Million | -14.37 Million | -6.87 Million | 91.89 Million |
| Debt repayment | - | - | -100 Million | -100 Million | - | -100 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -53.22 Million | -53.22 Million | -19.65 Million | -12.21 Million | -6.18 Million | -7.27 Million |
| Common Stock Issuance | 68.99 Million | - | 1.15 Million | 182.83 Thousand | - | 961 Thousand |
| Other Financing Activities | 33.67 Million | 33.67 Million | -24 Thousand | 99.2 Million | -691 Thousand | -22.99 Thousand |
| Accounts receivables | 160 Thousand | 160 Thousand | 9.75 Million | 429.52 Thousand | 253.5 Thousand | 9.24 Million |
| Accounts payables | -16.88 Million | - | 3.84 Million | 13.13 Million | - | -9.31 Million |
| Inventory | - | - | - | - | - | -1.00 |
| Other working capital | -197 Thousand | -197 Thousand | 2.55 Million | 1.72 Million | 880 Thousand | 2.16 Million |
| Cash at beginning of period | 192.7 Million | - | 151.99 Million | 352.13 Million | - | 151.99 Million |
| Cash at end of period | 310.11 Million | 58.69 Million | 192.7 Million | 192.7 Million | -79.71 Million | 352.13 Million |
| Capital Expenditure | - | - | -245 Thousand | -173.05 Thousand | - | -70 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | -500 Thousand |
| Net cash flow / Change in cash | 117.4 Million | 58.69 Million | 40.71 Million | -159.43 Million | -79.71 Million | 200.14 Million |
| Free Cash Flow | -40 Million | -40 Million | -106.16 Million | -40.11 Million | -20.39 Million | -65.2 Million |
WNLV
002395
KIM-PM
035510
FLR
3339